This site is intended for health professionals only

Published on 8 September 2009

Share this story:

Update on velaglucerase alfa


Shire plc, theglobal specialty biopharmaceutical company, is committed to doingeverything possible to assist Gaucher patients and their physiciansduring the imiglucerase supply shortage. Shire is pleased to be able toprovide velaglucerase alfa well over a year ahead of previouslyanticipated commercial launch world wide.

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine